Used primarily in research settings as a selective antagonist for the CCR5 chemokine receptor, this compound plays a role in studies related to HIV infection, as CCR5 is a co-receptor involved in viral entry into host cells. It helps in understanding receptor function and signaling pathways in immune cells. Additionally, it has been employed in neuroscience research to investigate the role of CCR5 in neuroinflammation and pain modulation. Due to its ability to block CCR5, it serves as a tool compound for exploring potential therapeutic targets in inflammatory diseases and central nervous system disorders.